The first-in-human study will be conducted in collaboration with the H. Lee Moffitt Cancer Center & Research Institute, it said.
Price: 4.64, Change: +0.07, Percent Change: +1.42
|MiMedx Says Glass Lewis Recommends in Favor of Direc...|
|T2 Biosystems Says It Secured US Patent Covering Met...|
|TherapeuticsMD Gets FDA Approval for Supplemental Ne...|
|Deere Raises Fiscal 2022 Profit Outlook After Postin...|
|Covetrus Says it Gets Proposal From Clayton, Dubilie...|